Sickle Cell Medical Advocacy Inc (EIN 872303319) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Legal Domicile

Tax Period

2025-01-01 to 2025-12-31

Sickle Cell Medical Advocacy Inc is a small nonprofit in the Education sector that reported $491K in total revenue in fiscal year 2025. Revenue surged 21% from the prior year, signaling strong growth momentum. Expenses of $475K left a modest 3% surplus.

Mission

Sickle Cell Medical Advocacys (SCMA) mission is to navigate transformative healthcare for patients with Sickle Cell disease, following national guidelines for urgent intervention and promoting faster healing and shorter hospitalizations.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $458,499

Program Service Revenue $31,985

Investment Income $0

Other Revenue $575

TOTAL REVENUE $491,059

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $412

Program Expenses $243,631

Other Expenses $474,958

TOTAL EXPENSES $475,370

Year-over-Year Comparison

	2025	2024	Change
Revenue	$491,059	$406,077	+0.2%
Expenses	$475,370	$400,753	+0.2%
Net Income	$15,689	$5,324	+1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Tamara Weston	President	4	Officer Director	$0	$0	$0
Sara Webb	Vice President	4	Officer Director	$0	$0	$0
Jennifer Valentin	Secretary	2	Officer Director	$0	$0	$0
Debi Sabotin	Treasurer	3	Officer Director	$0	$0	$0
Simone Uwan	Executive Director	4	Director Key Emp	$0	$0	$0
Aniekan Uwan	CFO	2	Director Key Emp	$0	$0	$0
Kara O'Connor	Board Member	1	Director	$0	$0	$0
Chandelic Melton	Board Member	2	Director	$0	$0	$0
Rita Hoyt	Board Member	1	Director	$0	$0	$0
Dale Hardaway	Board Member	2	Director	$0	$0	$0
Harry Williams	Board Member	1	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$491,059	$475,370	$49,426	$15,689
2024	$406,077	$400,753	$32,143	$5,324
2024	$406,077	$400,753	$32,143	$5,324
2023	$318,852	$326,233	$16,623	$-7,381
2023	$318,852	$326,233	$16,623	$-7,381

Sickle Cell Medical Advocacy Inc